Use of complementary medications among older adults with cancer

Cancer

Volumn 118, Issue 19, 2012, Pages 4815-4823

  Maggiore, Ronald J ^a   Gross, Cary P ^b   Togawa, Kayo ^c   Tew, William P ^d   Mohile, Supriya G ^e   Owusu, Cynthia ^f   Klepin, Heidi D ^g   Lichtman, Stuart M ^d   Gajra, Ajeet ^h   Ramani, Rupal ^c   Katheria, Vani ^c   Klapper, Shira M ^d   Hansen, Kurt ^c   Hurria, Arti ^c  

^a UNIVERSITY OF CHICAGO MEDICAL CENTER   (United States)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

^d MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^e UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

^f CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^g WAKE FOREST SCHOOL OF MEDICINE   (United States)

^h SUNY UPSTATE MEDICAL UNIVERSITY   (United States)

Author keywords

cancer. chemotherapy; complementary medicine; herbals; older adults

Indexed keywords

ALPHA TOCOPHEROL; ASCORBIC ACID; CHROMIUM; COD LIVER OIL; CURCUMIN; GLUCOSAMINE; GREEN TEA EXTRACT; HERBACEOUS AGENT; LINSEED OIL; MELATONIN; MINERAL; MULTIVITAMIN; PHOSPHATIDYLCHOLINE; PROBIOTIC AGENT; SELENIUM; UBIDECARENONE; VITAMIN; VITAMIN B GROUP; XANTHOPHYLL; ZINC;

ADL DISABILITY; ADVANCED CANCER; AGED; ALTERNATIVE MEDICINE; ANXIETY; ARTICLE; CANCER CHEMOTHERAPY; CANCER PATIENT; CANCER STAGING; COGNITIVE DEFECT; COHORT ANALYSIS; COMORBIDITY; DEPRESSION; DIET SUPPLEMENTATION; DRUG USE; FALLING; FEMALE; FUNCTIONAL STATUS; GERIATRIC PATIENT; HUMAN; MAJOR CLINICAL STUDY; MALE; MENTAL HEALTH; NUTRITIONAL STATUS; PRIORITY JOURNAL; WEIGHT REDUCTION;

AGED; AGED, 80 AND OVER; COMORBIDITY; DIETARY SUPPLEMENTS; FEMALE; HUMANS; MALE; NEOPLASMS; NONPRESCRIPTION DRUGS; PLANT PREPARATIONS;

EID: 84866489453     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.27427     Document Type: Article

References (49)

1. Ernst E, Cassileth BR,. The prevalence of complementary/alternative medicine in cancer: a systematic review. Cancer. 1998; 83: 777-782.
2. Richardson MA, Sanders T, Palmer JL, Greisinger A, Singletary SE,. Complementary/alternative medicine use in a comprehensive cancer center and the implications for oncology. J Clin Oncol. 2000; 18: 2505-2514.
3. Sparber A, Bauer L, Curt G, et al. Use of complementary medicine by adult patients participating in cancer clinical trials. Oncol Nurs Forum. 2000; 27: 623-630.
4. Bernstein BJ, Grasso T,. Prevalence of complementary and alternative medicine use in cancer patients. Oncology (Williston Park). 2001; 15: 1267-1272; discussion 1272-1278, 1283.
5. McCune JS, Hatfield AJ, Blackburn AA, Leith PO, Livingston RB, Ellis GK,. Potential of chemotherapy-herb interactions in adult cancer patients. Support Care Cancer. 2004; 12: 454-462.
6. Gupta D, Lis CG, Birdsall TC, Grutsch JF,. The use of dietary supplements in a community hospital comprehensive cancer center: implications for conventional cancer care. Support Care Cancer. 2005; 13: 912-919.
7. Lee MM, Chang JS, Jacobs B, Wrensch MR,. Complementary and alternative medicine use among men with prostate cancer in 4 ethnic populations. Am J Public Health. 2002; 92: 1606-1609.
8. Lee MM, Lin SS, Wrensch MR, Adler SR, Eisenberg D,. Alternative therapies used by women with breast cancer in 4 ethnic populations. J Natl Cancer Inst. 2000; 92: 42-47.
9. Astin JA, Reilly C, Perkins C, Child WL,. Breast cancer patients' perspectives on and use of complementary and alternative medicine: a study by the Susan G. Komen Breast Cancer Foundation J Soc Integr Oncol. 2006; 4: 157-169.
10. Lawsin C, DuHamel K, Itzkowitz SH, et al. Demographic, medical, and psychosocial correlates to CAM use among survivors of colorectal cancer. Support Care Cancer. 2007; 15: 557-564.
11. Wells M, Sarna L, Cooley ME, et al. Use of complementary and alternative medicine therapies to control symptoms in women living with lung cancer. Cancer Nurs. 2007; 30: 45-55; quiz 56-57.
12. Matthews AK, Sellergren SA, Huo D, List M, Fleming G,. Complementary and alternative medicine use among breast cancer survivors. J Altern Complement Med. 2007; 13: 555-562.
13. Patterson RE, Neuhouser ML, Hedderson MM, et al. Types of alternative medicine used by patients with breast, colon, or prostate cancer: predictors, motives, and costs. J Altern Complement Med. 2002; 8: 477-485.
14. Henderson JW, Donatelle RJ,. Complementary and alternative medicine use by women after completion of allopathic treatment for breast cancer. Altern Ther Health Med. 2004; 10: 52-57.
15. Lippert MC, McClain R, Boyd JC, Theodorescu D,. Alternative medicine use in patients with localized prostate carcinoma treated with curative intent. Cancer. 1999; 86: 2642-2648.
16. Wyatt GK, Friedman LL, Given CW, Given BA, Beckrow KC,. Complementary therapy use among older cancer patients. Cancer Pract. 1999; 7: 136-144.
17. Nahin RL, Fitzpatrick AL, Williamson JD, Burke GL, Dekosky ST, Furberg C,. Use of herbal medicine and other dietary supplements in community-dwelling older people: baseline data from the ginkgo evaluation of memory study. J Am Geriatr Soc. 2006; 54: 1725-1735.
18. Bruno JJ, Ellis JJ,. Herbal use among US elderly: 2002 National Health Interview Survey. Ann Pharmacother. 2005; 39: 643-648.
19. Qato DM, Alexander GC, Conti RM, Johnson M, Schumm P, Lindau ST,. Use of prescription and over-The-counter medications and dietary supplements among older adults in the United States. JAMA. 2008; 300: 2867-2878.
20. Cheung CK, Wyman JF, Halcon LL,. Use of complementary and alternative therapies in community-dwelling older adults. J Altern Complement Med. 2007; 13: 997-1006.
21. Elmer GW, Lafferty WE, Tyree PT, Lind BK,. Potential interactions between complementary/alternative products and conventional medicines in a Medicare population. Ann Pharmacother. 2007; 41: 1617-1624.
22. Slone Epidemiology Center at Boston University. Patterns of Medication Use in the United States: A Report of the Slone Survey. Boston, MA: Slone Epidemiology Center; 2006. Available from: http://www.bu.edu/slone/SloneSurvey/ AnnualRpt/SloneSurveyWebReport2006.pdf. [Accessed on September 1, 2011.]
23. Engdal S, Klepp O, Nilsen OG,. Identification and exploration of herb-drug combinations used by cancer patients. Integr Cancer Ther. 2009; 8: 29-36.
24. Sparreboom A, Cox MC, Acharya MR, Figg WD,. Herbal remedies in the United States: potential adverse interactions with anticancer agents. J Clin Oncol. 2004; 22: 2489-2503.
25. Hurria A, Mohile S, Lichtman S, Owusu C,. Geriatric assessment of older adults with cancer: baseline data from 500 patient multicenter study [abstract]. J Clin Oncol. 2009; 27 (15). Abstract 9546.
26. Hurria A, Lichtman SM, Gardes J, et al. Identifying vulnerable older adults with cancer: integrating geriatric assessment into oncology practice. J Am Geriatr Soc. 2007; 55: 1604-1608.
27. Hurria A, Gupta S, Zauderer M, et al. Developing a cancer-specific geriatric assessment: a feasibility study. Cancer. 2005; 104: 1998-2005.
28. National Cancer Institute. National Cancer Institute Dictionary of Cancer Terms. Available from: http://www.cancer.gov/dictionary/?CdrID=44384. [Accessed on September 1, 2011.]
29. Arcury TA, Suerken CK, Grzywacz JG, Bell RA, Lang W, Quandt SA,. Complementary and alternative medicine use among older adults: ethnic variation. Ethn Dis. 2006; 16: 723-731.
30. Grzywacz JG, Suerken CK, Quandt SA, Bell RA, Lang W, Arcury TA,. Older adults' use of complementary and alternative medicine for mental health: findings from the 2002 National Health Interview Survey. J Altern Complement Med. 2006; 12: 467-473.
31. Yates JS, Mustian KM, Morrow GR, et al. Prevalence of complementary and alternative medicine use in cancer patients during treatment. Support Care Cancer. 2005; 13: 806-811.
32. Shumay DM, Maskarinec G, Gotay CC, Heiby EM, Kakai H,. Determinants of the degree of complementary and alternative medicine use among patients with cancer. J Altern Complement Med. 2002; 8: 661-671.
33. Dy GK, Bekele L, Hanson LJ, et al. Complementary and alternative medicine use by patients enrolled onto phase I clinical trials. J Clin Oncol. 2004; 22: 4810-4815.
34. Chan JM, Elkin EP, Silva SJ, Broering JM, Latini DM, Carroll PR,. Total and specific complementary and alternative medicine use in a large cohort of men with prostate cancer. Urology. 2005; 66: 1223-1228.
35. Burstein HJ, Gelber S, Guadagnoli E, Weeks JC,. Use of alternative medicine by women with early stage breast cancer. N Engl J Med. 1999; 340: 1733-1739.
36. Bardia A, Greeno E, Bauer BA,. Dietary supplement usage by patients with cancer undergoing chemotherapy: does prognosis or cancer symptoms predict usage? J Support Oncol. 2007; 5: 195-198.
37. Hurria A, Togawa K, Mohile SG, et al. Predicting chemotherapy toxicity in older adults with cancer: a prospective multicenter study. J Clin Oncol. 2011; 29: 3457-3465.
38. Fillenbaum GG, Smyer MA,. The development, validity, and reliability of the OARS multidimensional functional assessment questionnaire. J Gerontol. 1981; 36: 428-434.
39. Yates JW, Chalmer B, McKegney FP,. Evaluation of patients with advanced cancer using the Karnofsky performance status. Cancer. 1980; 45: 2220-2224.
40. Karnofsky D, Burchenal J,. The clinical evaluation of chemotherapeutic agents in cancer. In:, MacLeod CM, ed. Evaluation of Chemotherapeutic Agents. New York: Columbia University Press; 1948: 191-205.
41. Ensrud KE, Ewing SK, Cawthon PM, et al. A comparison of frailty indexes for the prediction of falls, disability, fractures, and mortality in older men. J Am Geriatr Soc. 2009; 57: 492-498.
42. Ensrud KE, Ewing SK, Taylor BC, et al. Comparison of 2 frailty indexes for prediction of falls, disability, fractures, and death in older women. Arch Intern Med. 2008; 168: 382-389.
43. Ensrud KE, Ewing SK, Taylor BC, et al. Frailty and risk of falls, fracture, and mortality in older women: the study of osteoporotic fractures. J Gerontol A Biol Sci Med Sci. 2007; 62: 744-751.
44. Zigmond AS, Snaith RP,. The Hospital Anxiety and Depression Scale. Acta Psychiatr Scand. 1983; 67: 361-370.
45. Carroll BT, Kathol RG, Noyes R Jr, Wald TG, Clamon GH,. Screening for depression and anxiety in cancer patients using the Hospital Anxiety and Depression Scale. Gen Hosp Psychiatry. 1993; 15: 69-74.
46. Kawas C, Karagiozis H, Resau L, Corrada M, Brookmeyer R,. Reliability of the Blessed Telephone Information-Memory-Concentration test. J Geriatr Psychiatry Neurol. 1995; 8: 238-242.
47. Katzman R, Brown T, Fuld P, Peck A, Schechter R, Schimmel H,. Validation of a short Orientation-Memory-Concentration Test of cognitive impairment. Am J Psychiatry. 1983; 140: 734-739.
48. Lichtman SM, Boparai MK,. Geriatric medication management: evaluation of pharmacist interventions and potentially inappropriate medication (PIM) use in older (≥yen;65 years) cancer patients [abstract]. J Clin Oncol. 2009; 27 (15). Abstract 9507.
49. Ries LA, Wingo PA, Miller DS, et al. The annual report to the nation on the status of cancer, 1973-1997, with a special section on colorectal cancer. Cancer. 2000; 88: 2398-2424.